Revealed: Multinationals Flock To China’s No-Frills Insurance Initiatives

 
• By Dexter Jie Yan

Side-stepping annual drug price negotiations and resulting deep price cuts, multinational drug makers are looking elsewhere to an emerging niche medical insurance scheme in China as they hope to gain an edge versus local competitors.

Huimin Insurance
survey finds multinationals are carving out China market access pathway via Huiminbao insurance initiative • Source: Alamy

More from China

More from Asia